.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Medtronic
Mallinckrodt
Express Scripts
Colorcon
Dow
Baxter
UBS
Merck

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 079085

« Back to Dashboard
NDA 079085 describes CARBIDOPA, LEVODOPA AND ENTACAPONE, which is a drug marketed by Wockhardt Ltd and Sun Pharma Global and is included in three NDAs. It is available from one supplier. Additional details are available on the CARBIDOPA, LEVODOPA AND ENTACAPONE profile page.

The generic ingredient in CARBIDOPA, LEVODOPA AND ENTACAPONE is carbidopa; entacapone; levodopa. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the carbidopa; entacapone; levodopa profile page.

Summary for NDA: 079085

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 079085

Suppliers and Packaging for NDA: 079085

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARBIDOPA, LEVODOPA AND ENTACAPONE
carbidopa; entacapone; levodopa
TABLET;ORAL 079085 ANDA Sun Pharma Global FZE 47335-909 47335-909-08 100 TABLET, FILM COATED in 1 BOTTLE (47335-909-08)
CARBIDOPA, LEVODOPA AND ENTACAPONE
carbidopa; entacapone; levodopa
TABLET;ORAL 079085 ANDA Sun Pharma Global FZE 47335-909 47335-909-18 1000 TABLET, FILM COATED in 1 BOTTLE (47335-909-18)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG;200MG;100MG
Approval Date:May 10, 2012TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength37.5MG;200MG;150MG
Approval Date:May 10, 2012TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Julphar
US Department of Justice
Argus Health
Merck
Accenture
Moodys
Cipla
Cantor Fitzgerald
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot